Anika Therapeutics: Advancing Orthopedic Regenerative Medicine and Osteoarthritis Care

Anika Therapeutics specializes in hyaluronic acid-based solutions designed to manage osteoarthritis pain and support orthopedic tissue repair. The company’s portfolio focuses on regenerative medicine, utilizing proprietary technology to create injectable treatments and scaffolds that assist the body’s natural healing processes across global healthcare markets.

Hyaluronic Acid Technology in Orthopedic Care

At the core of Anika’s operations is a proprietary hyaluronic acid (HA) technology platform. According to the company, this platform serves as the foundation for a range of orthopedic products, including both non-opioid pain management injections and regenerative surgical solutions. The technology is engineered to mimic biological functions, aiming to reduce pain and improve mobility for patients suffering from osteoarthritis.

The company’s product line includes several notable solutions for joint health:

• Cingal: A combination treatment that merges hyaluronic acid and a steroid into a single injection, designed to provide immediate pain relief for up to six months while reducing stiffness.
• Monovisc: A single-injection HA viscosupplement intended for pain management.
• Orthovisc: A multi-injection HA viscosupplement.

Regenerative Solutions for Tissue Repair

Beyond pain management, Anika develops advanced solutions for tissue repair and bone health. These products are intended to harness the body’s innate ability to heal following injury or surgery.

Key regenerative offerings include:

• Integrity: A scaffold designed for rotator cuff and tendon repair augmentation. Christopher E. Baker, MD, of the Florida Orthopaedic Institute, notes that “Integrity significantly enhances both the strength and biological support in rotator cuff repairs.” He further states that patient outcomes have been positive, with postoperative imaging showing thickening of the repaired tissue.
• Hyalofast: A scaffold specifically developed for cartilage regeneration.
• Tactoset: An injectable bone substitute.
• NanoFx: A system designed for advanced bone marrow stimulation.

Clinical Impact and Patient Outcomes

The shift toward regenerative medicine in orthopedics aims to move beyond temporary symptom relief. By providing physical support for tissue regeneration, products like Integrity are used to help patients return to their daily activities. According to clinical observations provided by the company, patients using these regenerative solutions are consistently able to return to their desired life activities without restrictions.

As of June 2026, Anika continues to focus on the global expansion of these HA-based therapies, positioning its technology as a primary tool for surgeons and pain management specialists seeking non-opioid alternatives for musculoskeletal conditions.

Frequently Asked Questions

What is the primary function of Anika’s hyaluronic acid technology?
The technology is designed to reduce the pain of osteoarthritis, improve joint mobility, and provide biological support for tissue repair and regeneration.

How does Cingal differ from other injections?
Cingal combines two therapies—hyaluronic acid and a steroid—into a single injection, targeting both pain and inflammation simultaneously.

What is the purpose of the Integrity scaffold?
Integrity is used in rotator cuff and tendon repairs to enhance the strength and biological support of the repair site, facilitating better patient outcomes and tissue thickening.